Executive Chairman of Genomic Health Inc. (GHDX) Randal W Scott sells 20,000 shares of GHDX on 03/11/2011 at an average price of $25.62 a share.

Genomic Health Inc. has a market cap of $734.99 million; its shares were traded at around $25.47 with a P/E ratio of 181.93 and P/S ratio of 4.13.

This is the annual revenues and earnings per share of GHDX over the last 10 years. For detailed 10-year financial data and charts, go to 10-Year Financials of GHDX.

CEO Recent Trades:

• Sell: President and CEO Kimberly J Popovits sold 8,000 shares of GHDX stock on 02/15/2011 at the average price of 22.51. Kimberly J Popovits owns at least 319,424 shares after this. The price of the stock has increased by 13.15% since.
• Sell: President and CEO Kimberly J Popovits sold 8,000 shares of GHDX stock on 01/18/2011 at the average price of 21.15. Kimberly J Popovits owns at least 309,424 shares after this. The price of the stock has increased by 20.43% since.
• Sell: President and CEO Kimberly J Popovits sold 8,000 shares of GHDX stock on 01/18/2011 at the average price of 21.15. Kimberly J Popovits owns at least 309,424 shares after this. The price of the stock has increased by 20.43% since.
• Sell: President and CEO Kimberly J Popovits sold 8,000 shares of GHDX stock on 12/16/2010 at the average price of 22.71. Kimberly J Popovits owns at least 310,624 shares after this. The price of the stock has increased by 12.15% since.
• Sell: President and CEO Kimberly J Popovits sold 8,000 shares of GHDX stock on 11/16/2010 at the average price of 17.5. Kimberly J Popovits owns at least 310,624 shares after this. The price of the stock has increased by 45.54% since.

CFO Recent Trades:

• Sell: CFO Dean L Schorno sold 1,000 shares of GHDX stock on 02/15/2011 at the average price of 22.51. Dean L Schorno owns at least 29,049 shares after this. The price of the stock has increased by 13.15% since.
• Sell: CFO Dean L Schorno sold 1,276 shares of GHDX stock on 01/13/2011 at the average price of 21.06. Dean L Schorno owns at least 26,149 shares after this. The price of the stock has increased by 20.94% since.
• Sell: COO & CFO G Bradley Cole sold 2,500 shares of GHDX stock on 12/13/2010 at the average price of 22.64. G Bradley Cole owns at least 1,000 shares after this. The price of the stock has increased by 12.5% since.
• Sell: COO & CFO G Bradley Cole sold 2,500 shares of GHDX stock on 11/11/2010 at the average price of 18.04. G Bradley Cole owns at least 1,000 shares after this. The price of the stock has increased by 41.19% since.

This is the insider trade history vs. stock price of GHDX. For the complete insider trading history of GHDX, click here.

Directors and Officers Recent Trades:

• Buy: Director, 10% Owner Brothers Life Sciences C Baker bought 70,856 shares of GHDX stock on 03/10/2011 at the average price of 26.03. Brothers Life Sciences C Baker owns at least 5,674,104 shares after this. The price of the stock has decreased by 2.15% since.
• Buy: Director, 10% Owner Brothers Life Sciences C Baker bought 349,566 shares of GHDX stock on 03/08/2011 at the average price of 25.06. Brothers Life Sciences C Baker owns at least 5,603,248 shares after this. The price of the stock has increased by 1.64% since.
• Buy: Director, 10% Owner Capital (gp), Llc 14159 bought 9,648 shares of GHDX stock on 03/08/2011 at the average price of 25.06. Capital (gp), Llc 14159 owns at least 152,640 shares after this. The price of the stock has increased by 1.64% since.
• Buy: Director, 10% Owner Capital (gp), Llc 14159 bought 4,426 shares of GHDX stock on 03/02/2011 at the average price of 25.69. Capital (gp), Llc 14159 owns at least 142,992 shares after this. The price of the stock has decreased by 0.86% since.
• Buy: Director, 10% Owner Brothers Life Sciences C Baker bought 160,337 shares of GHDX stock on 03/02/2011 at the average price of 25.69. Brothers Life Sciences C Baker owns at least 5,253,682 shares after this. The price of the stock has decreased by 0.86% since.

For the complete insider trading history of GHDX, click here.

Why CEOs Are Buying Stocks Of Their Own Companies?

1. As legendary investor Peter Lynch said: "Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise."
2. TOP EXECUTIVES like CEOs and CFOs are savvy buyers of their companies' shares. One long-term study showed that they beat the market on average by six percentage points a year.
3. Another study found that the aggregated activities of insiders can serve as a good indicator to locate market bottoms. Insiders as a whole are smart investors of their own companies.

Click it to Check Out What the CEO Are Trading

More Gurufocus Links

Latest Guru Picks	Value Strategies
Warren Buffett Portfolio	Ben Graham Net-Net
Real Time Picks	Buffett-Munger Screener
Aggregated Portfolio	Undervalued Predictable
ETFs, Options	Low P/S Companies
Insider Trends	10-Year Financials
52-Week Lows	Interactive Charts
Model Portfolios	DCF Calculator
RSS Feed	Monthly Newsletters
The All-In-One Screener	Portfolio Tracking Tool